Member Info for djm1

Very Impressive, so undervalued, endorsed by the two most significant Gastro Intestinal Medical bodies in the US with exclusive agreements to help their memebers and doctors with big contracts coming on line. Only need a tiny fraction of the addressable market to break even. The two Gastro Intestinal organisations will access all of the adressable market.

3.30 monday, live, link address bottom of RNS

Seems some cant wait till Monday, they were hoping for a bag today, when the forward plans are fleshed out on Monday some sense should hopefully prevail.

Looks like rerate will have to wait till after Monday's presentation, it will be on a few more people's radar then, everyone loves a bargain.

What was the closing price here today? I know what it says here but ii saying 7.5p

Is that a realistic price prediction for a bid Pidster?

· The final group of subjects completed dosing on 30 March 2022. This was a group of subjects that received an intravenous injection of a 800 mcg dose of P140, which showed successful measurement of the absolute bioavailability of the drug (as a control)



· Importantly, and in-line with all human dosing to date, P140 was safe and well tolerated across all doses and in all subjects



· This positive PK data now clears the path for commencement of all clinical studies within the P140 platform. In addition to lupus, there is a planned Phase 2a/3 pivotal trial in chronic inflammatory demyelinating polyneuropathy ("CIDP")



· Avion Pharmaceuticals, our US partner, has been integral to the development, initiation and successful conclusion of this PK study. Together, we are preparing next steps for the progression of the P140 clinical program and this will be communicated in due course.

So do you think another phase 2 trial is required?

There was a clear implication that by following the guidance regulatory approval would follow, now that is significant in my view. So faced with a potential billion dollar revenue stream and as good a road map as you are likely to get, do you throw your cards in or incorporate the changes.

Lambo, what was the thumbs down? Did the RNS say that?

Lambo, you were giving it super large last week now its turn out the lights, what a piece of **** you are

Agreed, nothing significant in terms of size at all.

We know its not a no, its a yes with advice on how to proceed

Dallo, thats how i read it, yes its not immediate but its as clear a sign that if yu do it like this then regulatory approval will follow

Letter says" dont do it like that , do it like this" to improve regulatory approval.... so its not a no its a yes but slightly differently. Is it so different that Aveon won't fund it now they've been given further guidance on how to get regulatory approval?

just watching the investor presentation again, both Tims saying P3 trial going ahead after working closely with the FDA and they've ponied up £100k as a board in the fund raising. Open admission of where it went wrong previously and other irons in the fire. I understand if people are underwater they are bitter and once bitten twice shy, but it feels positive to me.
Fingers crossed for everyone.

Thanks LLL.

LLL,
if they apply conditions you dont think Avion will carry on?

Nolupus.
i take it you are not holding then because of this?

Spread is **** take

Well its never bad to get a bit of publicity but it didnt fly in to close, traders took their 5%,if they even got that with the ridiculous spread.